Craniopharyngioma pathophysiology

Jump to navigation Jump to search

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma pathophysiology

CDC on Craniopharyngioma pathophysiology

Craniopharyngioma pathophysiology in the news

Blogs on Craniopharyngioma pathophysiology

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma pathophysiology

  1. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Craniopharyngiomas are epithelial tumors that usually arise in the pituitary stalk adjacent to the optic chiasm. On gross pathology, craniopharyngiomas are cystic or partially cystic with solid areas.The cyst is filled with a turbid, proteinaceous material of brownish-yellow color that glitters and sparkles because of a high content of floating cholesterol crystals On microscopic histopathology, it is categorized into two subtypes: Adamantinomatous and papillary.

Pathophysiology

  • Craniopharyngioma is a nonglial intracranial tumor derived from a malformation of embryonic tissue.
  • There are differing hypotheses on its embryonic origin: originating from ectodermal remnants of Rathke's pouch vs originating from residual embryonal epithelium of the anterior pituitary gland and of the anterior infundibulum.

Gross Pathology

  • On macroscopic examination, craniopharyngiomas are cystic or partially cystic with solid areas. [1]
  • It occur most often in sellar/suprasellar region but can have anterior extension to the prechiasmatic cistern and subfrontal spaces.[1]
  • Posterior extension into the prepontine and interpeduncular cisterns, cerebellopontine angle, third ventricle, posterior fossa, and foramen magnum; and laterally toward the subtemporal spaces.[1]
  • Craniopharyngiomas are supplied with blood coming from the anterior circulation: perforators from anterior cerebral artery and the proximal portion of the posterior communicating artery.[2]
  • Tumor adhesion is the result of local inflammation. Several inflammatory cytokines have been shown to be elevated in the craniopharyngioma cyst fluid compared with cerbrospinal fluid (CSF).[3]

Microscopic pathology

  • The histologic pattern consists of nesting of squamous epithelium bordered by radially arranged cells. It is frequently accompanied by calcium deposition and have a microscopic papillary architecture.
  • Two distinct types are recognized:[4][5]
  1. Adamantinomatous craniopharyngioma
  2. Papillary craniopharyngioma.
  • In the adamantinomatous type, calcifications are visible on neuroimaging and are helpful in diagnosis.
  • The papillary type rarely calcifies. On light microscopy, the cysts are seen to be lined by stratified squamous epithelium.
  • Keratin pearls may also be seen.
  • The cysts are usually filled with a yellow, viscous fluid which is rich in cholesterol crystals.
  • Islands of densely packed cells merge with loosely cohesive aggregates of squamous cells known as stellate reticulum.
  • Nodules of “wet keratin” representing remnants of pale nuclei embedded within an eosinophilic keratinous mass are found in either the compact or looser areas.
  • Cystic cavities containing squamous debris are lined by flattened epithelium.
  • Granulomatous inflammation associated with cholesterol clefts and giant cells may be detectable, but this is more typical for xanthogranuloma.
  • Piloid gliosis with abundant Rosenthal fibers is often seen at the infiltrative interface of the tumor and should not be mistaken for pilocytic astrocytoma.
  • Malignant transformation” of craniopharyngioma appears to be very rare.
  • Shown below is a micrograph showing the characteristic features of an adamantinomatous craniopharyngioma - cystic spaces, calcifications, and "wet keratin" pearls on hematoxylin phloxine saffron (HPS) stain.


  • Shown below is a Micrograph showing a papillary craniopharyngioma on HPS stain.


Genetics

  • Multiple chromosomal abnormalities have been reported by classic cytogenetic analysis.
  • Most tumors had abnormalities involving chromosomes 2 and 12.
  • More than 70% of adamantinomatous craniopharyngiomas harbor a mutation of the β-catenin gene.
  • Most of the mutations affect exon 3, which encodes the degradation targeting box of β-catenin compatible with an accumulation of nuclear β-catenin protein.
  • In a few cases of adamantinomatous craniopharyngioma, the same β-catenin mutations occurring in the epithelial cells have been identified in mesenchymal cells.
  • No mutations have been demonstrated in papillary craniopharyngioma.
  • Comparative genomic hybridization studies on two large series of craniopharyngiomas have failed to show significant chromosomal imbalances in adamantinomatous and papillary craniopharyngioma.

References

  1. 1.0 1.1 1.2 Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC (December 1994). "Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome". Neurosurgery. 35 (6): 1001–10, discussion 1010–1. PMID 7885544.
  2. Duff J, Meyer FB, Ilstrup DM, Laws ER, Schleck CD, Scheithauer BW (February 2000). "Long-term outcomes for surgically resected craniopharyngiomas". Neurosurgery. 46 (2): 291–302, discussion 302–5. PMID 10690718.
  3. Garrè ML, Cama A (August 2007). "Craniopharyngioma: modern concepts in pathogenesis and treatment". Curr. Opin. Pediatr. 19 (4): 471–9. doi:10.1097/MOP.0b013e3282495a22. PMID 17630614.
  4. Sekine S, Shibata T, Kokubu A; et al. (2002). "Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations". Am. J. Pathol. 161 (6): 1997–2001. PMC 1850925. PMID 12466115. Unknown parameter |month= ignored (help)
  5. Sekine S, Takata T, Shibata T; et al. (2004). "Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation". Histopathology. 45 (6): 573–9. doi:10.1111/j.1365-2559.2004.02029.x. PMID 15569047. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources